1-11 of 11
Kuo-Kai Chin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase II study of IDH1 inhibition with ivosidenib as maintenance therapy after ivosidenib, azacitidine, and venetoclax for Acute Myeloid Leukemia: Trial in progress

Free
Kuo-Kai Chin, Andriy Derkach, Leora Boussi, Gabrielle Melamed, Giulia Petrone, Kelly Bolton, Maher Abdul Hay, Jessica Altman, Andrew Intlekofer, Eytan Stein
Journal: Blood
Blood (2025) 146 (Supplement 1): 1690.
https://doi.org/10.1182/blood-2025-1690
Published: 2025
Journal Articles

A Phase 1/2 study of the menin inhibitor revumenib with the celmod mezigdomide in relapsed/refractory KMT2A-rearanged, NPM1-mutant, and NUP98-rearranged acute leukemias

Free
Kuo-Kai Chin, Sheng Cai, Andriy Derkach, Gabrielle Melamed, Natalie Smith, Neerav Shukla, Joshua Zeidner, Ibrahim Aldoss, Ghayas Issa, Eytan Stein
Journal: Blood
Blood (2025) 146 (Supplement 1): 1657.
https://doi.org/10.1182/blood-2025-1657
Published: 2025
Journal Articles

The outcomes of patients who are relapsed or refractory to menin inhibitors is poor with a limited overall survival

Free
Kuo-Kai Chin, Brian Ball, Yasmin Abaza, Jessica Altman, Rahul Thakur, Moiez Ali, Andriy Derkach, Mark Geyer, Aaron Goldberg, Tamanna Haque, Meghan Thompson, Jae Park, Martin Tallman, Sheng Cai, Eunice Wang, Ibrahim Aldoss, Eytan Stein
Journal: Blood
Blood (2025) 146 (Supplement 1): 39.
https://doi.org/10.1182/blood-2025-39
Published: 2025
Journal Articles

Real-world administration blinatumomab in the outpatient setting: Toxicity outcomes and healthcare utilization

Free
Yannis Valtis, Benjamin Frost, David Nemirovsky, Andriy Derkach, Kuo-Kai Chin, Meira Yisraeli Salman, Leora Boussi, Natalia Tijaro Ovalle, Eytan Stein, Emilie Baxter, Mark Geyer, Marlise Luskin, Daniel Deangelo, Jae Park, Evan Chen
Journal: Blood
Blood (2025) 146 (Supplement 1): 1078.
https://doi.org/10.1182/blood-2025-1078
Published: 2025
Journal Articles

Real-world treatment patterns and outcomes among patients with newly diagnosed NPM1-mutated acute myeloid leukemia in the United States

Free
Kuo-Kai Chin, Grace Gahlon, Lorena Lopez-Gonzalez, Shailja Vaghela, Craig Freyer, Shelby Corman, Huan Huang, Aaron Goldberg
Journal: Blood
Blood (2025) 146 (Supplement 1): 3385.
https://doi.org/10.1182/blood-2025-3385
Published: 2025
Journal Articles

Prognosis in adults with ph-positive B-ALL in first complete remission without minimal residual disease after blinatumomab consolidation is influenced by minimal residual disease (≥10-4) pre-blinatumomab

Free
Benjamin Frost, Yannis Valtis, Yael Flamand, Emilie Baxter, David Nemirovsky, Andriy Derkach, Kuo-Kai Chin, Meira Yisraeli Salman, Leora Boussi, Natalia Tijaro Ovalle, Eytan Stein, Mark Geyer, Shai Shimony, Jacqueline Garcia, Martha Wadleigh, Eric Winer, Virginia Volpe, Maximilian Stahl, Richard Stone, Daniel Deangelo, Jae Park, Marlise Luskin, Evan Chen
Journal: Blood
Blood (2025) 146 (Supplement 1): 3329.
https://doi.org/10.1182/blood-2025-3329
Published: 2025
Journal Articles

Barriers to Immune Effector Cell Therapy: Rapid Disease Progression, Concern for Toxicity, and Lack of Appropriate Trials Drive Non-Receipt after Referral at a Large Academic Center

Free
Yannis K. Valtis, Kuo-Kai Chin, Meira Yisraeli Salman, Leora Boussi, Briana Cadzin, Carina Mcloughlin, Elizabeth Cathcart, Paul Davis, Chelsea Brooklyn, Todd Goldstein, Christopher Famulare, Gunjan L. Shah, Moneeza Walji, Alexander P. Boardman, Roni Shouval, Eytan M. Stein, Sham Mailankody, Maria Lia Palomba, Gilles Salles, Sergio Giralt, Miguel Angel Perales, Jae H. Park
Journal: Blood
Blood (2024) 144 (Supplement 1): 781.
https://doi.org/10.1182/blood-2024-200915
Published: 2024
Journal Articles

HMA/Ven Treatment Modifications and Associated Outcomes in IDH -Mutant AML

Free
Kuo-Kai Chin, Andriy Derkach, Christopher Famulare, Gaurav Gupta, Prabhakar Borge, Mark Blaine Geyer, Aaron D. Goldberg, Tamanna Haque, Jae H. Park, Lindsey Roeker, Martin S. Tallman, Maximilian Stahl, Eytan M. Stein
Journal: Blood
Blood (2024) 144 (Supplement 1): 5962.
https://doi.org/10.1182/blood-2024-211733
Published: 2024
Journal Articles

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated with Upregulation of HOX Genes: Trial in Progress

Free
Ghayas C. Issa, Kuo-Kai Chin, James S. Blachly, Aziz Farhat, Lianchun Xiao, Jing Ning, Branko Cuglievan, Neerav Shukla, Koji Sasaki, Sanam Loghavi, Sheng Cai, Hagop M. Kantarjian, Eytan M. Stein
Journal: Blood
Blood (2024) 144 (Supplement 1): 5995.
https://doi.org/10.1182/blood-2024-203466
Published: 2024
Journal Articles

Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Response to Intensive Induction Chemotherapy, Suggesting Futility of Mid-Cycle Bone Marrow Biopsy and Caution When Considering Re-Induction

Free
Meira Yisraeli Salman, Alexander R. Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin, Yannis K. Valtis, Leora Boussi, Theresa Spivey, Wenbin Xiao, Christopher Famulare, Jenna Ciervo, Jacob M. Rowe, Martin S. Tallman, Eytan M. Stein
Journal: Blood
Blood (2024) 144 (Supplement 1): 2847.
https://doi.org/10.1182/blood-2024-193242
Published: 2024
Journal Articles

Despite High Rates of Remission, Treatment of IDH-Mutant AML with Hypomethylating Agents and Venetoclax Is Associated with Frequent Treatment Delays, Modifications, and Transfusions

Free
Kuo-Kai Chin, Andriy Derkach, Christopher Famulare, Gaurav Gupta, Prabhakar Borge, Ellin Berman, Mark Blaine Geyer, Aaron D. Goldberg, Tamanna Haque, Raajit K. Rampal, Jae H. Park, Lindsey E. Roeker, Martin S. Tallman, Eytan M. Stein
Journal: Blood
Blood (2023) 142 (Supplement 1): 1519.
https://doi.org/10.1182/blood-2023-182012
Published: 2023